Number of lymph node metastases influences survival in patients with thoracic esophageal carcinoma: therapeutic value of radiation treatment for recurrence
Authors:
- 1 November 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 12 (3) , 205-208
Abstract
Summary. We retrospectively investigated whether the number of involved lymph nodes and the radiation therapy for recurrence affect survival in patients with tKeywords
This publication has 8 references indexed in Scilit:
- The number of lymph node metastases influences survival in esophageal cancerJournal of Surgical Oncology, 1998
- Proposed Revision Of The Staging Classification For Esophageal CancerThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Surgical treatment for carcinoma of the thoracic esophagus with major involvement in the neck or upper mediastinumJournal of Surgical Oncology, 1998
- Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinomaCancer, 1997
- Induction Chemoradiotherapy Followed by Esophagectomy in Patients With Carcinoma of the EsophagusThe Annals of Thoracic Surgery, 1997
- Historical control bias: adjuvant chemotherapy in esophageal cancerDiseases of the Esophagus, 1997
- Analysis of results of surgery performed over a 20-year period on 500 patients with cancer of the thoracic esophagusSurgery Today, 1996
- Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma.Journal of Clinical Oncology, 1996